Altmetric – Intentional Weight Loss and Dose Reductions of Anti-Diabetic Medications

Title	Intentional Weight Loss and Dose Reductions of Anti-Diabetic Medications – A Retrospective Cohort Study
Published in	PLOS ONE, February 2012
DOI	10.1371/journal.pone.0032395
Pubmed ID	22384240
Authors	Anita Ashok Kumar, Ghanshyam Palamaner Subash Shantha, Scott Kahan, Rohit Joshua Samson, Nelson David Boddu, Lawrence Jay Cheskin
Abstract	Intentional weight loss, primarily by improving insulin resistance, is known to decrease the need for anti-diabetic medications. In this study, we assess the magnitude of weight loss that resulted in dose reductions or discontinuation of anti-diabetic medications in overweight or obese patients with type 2 diabetes (DM) undergoing weight loss treatment.

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.

Country	Count	As %
United States	3	75%
Unknown	1	25%

Type	Count	As %
Members of the public	4	100%

Mendeley readers

The data shown below were compiled from readership statistics for 43 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Readers by professional status	Count	As %
Student > Bachelor	10	23%
Student > Master	10	23%
Student > Ph. D. Student	4	9%
Professor	3	7%
Student > Postgraduate	3	7%
Other	6	14%
Unknown	7	16%

Readers by discipline	Count	As %
Medicine and Dentistry	23	53%
Pharmacology, Toxicology and Pharmaceutical Science	9	21%
Nursing and Health Professions	1	2%
Business, Management and Accounting	1	2%
Social Sciences	1	2%
Other	1	2%
Unknown	7	16%

PLOS